Gf Fund Management Co. Ltd. Novavax Inc Transaction History
Gf Fund Management Co. Ltd.
- $5.51 Trillion
- Q3 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,494 shares of NVAX stock, worth $24,353. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,494
Previous 4,101
14.8%
Holding current value
$24,353
Previous $25.8 Million
17.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVAX
# of Institutions
310Shares Held
95.7MCall Options Held
5.7MPut Options Held
9.06M-
Vanguard Group Inc Valley Forge, PA15.2MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
Shah Capital Management11.8MShares$82.3 Million45.37% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.27MShares$29.8 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...